Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Hyoscine Butylbromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,343Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Buscopan withdrawn from the market has substitutes
    Buscopan withdrawn from the market has substitutes

    10 Aug 2017

    // ANVISA

    https://www.pharmacompass.com/pdf/news/buscopan-withdrawn-from-the-market-has-substitutes-1502426530.pdf

    ANVISA
    10 Aug 2017
    Share Share
    Drugmaker Ipsen to buy some products from Sanofi for 83 million euros
    Drugmaker Ipsen to buy some products from Sanofi for 83 million euros

    14 Feb 2017

    // Sudip Kar-Gupta REUTERS

    http://www.reuters.com/article/us-sanofi-fr-m-a-ipsen-idUSKBN15S08J?feedType=RSS&feedName=healthNews

    Sudip Kar-Gupta REUTERS
    14 Feb 2017
    Share Share
    Anvisa Suspends Distribution of Ceara Ltds’ Injectable Products on Failing the Look Test
    Anvisa Suspends Distribution of Ceara Ltds’ Injectable Products on Failing the Look Test

    08 Apr 2015

    // ANVISA

    http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+medicamento+por+nao+passar+no+ensaio+de+aspecto

    ANVISA
    08 Apr 2015
    Share Share